Abstract
Migraine is a common medical condition characterized by recurrent episodes of moderate to severe head pain lasting hours or days and accompanied by other associated symptoms [1]. The head pain is usually throbbing or pulsatile in nature and experienced unilaterally (on one side of the head) and commonly accompanied by nausea, vomiting, or sensitivity to both light (photophobia) and sound (phonophobia). The presence of the latter symptoms conveys that migraine is far more than a typical “headache.” Because of the high pain severity and other debilitating symptoms, migraine attacks frequently interfere with activities of daily living, and patients experiencing migraine (migraineurs) often seek respite in a low-stimulus environment such as a dark quiet room.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Headache Classification Committee of the International Headache Society. The international classification of headache disorders. 3rd ed. (beta version). Cephalalgia. 2013;33:629–808.
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; for the American Migraine Prevalence and Prevention Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;280:2163–96.
Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55:21–34.
Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53:427–36.
Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52:1456–70.
Kelman R. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402.
Houle TT, Butschek RA, Turner DP, Smitherman TA, Rains JC, Penzien DB. Stress and sleep duration predict headache severity in chronic headache sufferers. Pain. 2012;153:2432–40.
Turner DP, Smitherman TA, Martin VT, Penzien DB, Houle TT. Causality and headache triggers. Headache. 2013;53:628–35.
Åsberg AN, Stovner LJ, Zwart JA, Winsvold BS, Heuch I, Hagen K. Migraine as a predictor of mortality: the HUNT study. Cephalalgia. 2015. [Epub ahead of print].
Schürks M, Rist PM, Shapiro RE, Kurth T. Migraine and mortality: a systematic review and meta-analysis. Cephalalgia. 2011;31:1301–14.
Saunders K, Merikangas K, Low NCP, Von Korff M, Kessler RC. Impact of comorbidity on headache-related disability. Neurology. 2008;70:534–47.
Mawet J, Kurth T, Ayata C. Migraine and stroke: in search of shared mechanisms. Cephalalgia. 2015;35:165–81.
Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.
Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427–34.
Chai NC, Scher AI, Moghekar A, Bond DS, Peterline BL. Obesity and headache: part I – a systematic review of the epidemiology of obesity and headache. Headache. 2014;54:219–34.
Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5:148–57.
Baskin SM, Smitherman TA. Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci. 2009;30 Suppl 1:S61–5.
Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998;18 Suppl 22:56–61.
Davis RE, Smitherman TA, Baskin SM. Personality traits, personality disorders, and migraine: a review. Neurol Sci. 2013;34 Suppl 1:7–10.
Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260:1960–9.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157–68.
Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106:81–9.
Houle TT, Turner DP, Smitherman TA, Penzien DB, Lipton RB. Influence of random measurement error on estimated rates of headache chronification and remission. Headache. 2013;53:920–9.
Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006;46:1334–43.
Goadbsy PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience. 2009;161:327–41.
Maizels M, Aurora S, Heinricher M. Beyond neurovascular: migraine as a dysfunctional neurolimbic pain network. Headache. 2012;10:1553–65.
Maniyar FH, Sprenger T, Monteith T, Schankin CJ, Goadsby PJ. The premonitory phase of migraine: what can we learn from it? Headache. 2015;55:609–20.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Smitherman, T.A. (2016). Introduction. In: Clinician's Manual on Migraine. Adis, Cham. https://doi.org/10.1007/978-3-319-02777-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-02777-7_1
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-02776-0
Online ISBN: 978-3-319-02777-7
eBook Packages: MedicineMedicine (R0)